The Expanding Role of FcRn Blockers to Achieve Minimal Symptom Expression in Patients with Generalized Myasthenia Gravis
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients with Psoriatic Arthritis
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts